Nebracetam

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nebracetam
Nebracetam.svg
Nebracetam3d.png
Clinical data
ATC code
  • none
Legal status
Legal status
  • US: Unscheduled Not FDA approved
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C12H16N2O
Molar mass 204.268 g/mol
3D model (Jmol)
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats.[1] Its effects in humans have not been studied.

See also[edit]

References[edit]

  1. ^ Takeo, S.; Hayashi, H.; Miyake, K.; Takagi, K.; Tadokoro, M.; Takagi, N.; Oshikawa, S. (1997). "Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats". British Journal of Pharmacology. 121 (3): 477–484. PMC 1564714Freely accessible. PMID 9179389. doi:10.1038/sj.bjp.0701161.